Exposure to nicotine-derived nitrosamine ketone and arecoline synergistically facilitates tumor aggressiveness via overexpression of epidermal growth factor receptor and its downstream signaling in head and neck squamous cell carcinoma

PloS One
Shih-Hsien YangFu-Huang Lin

Abstract

Long-term nicotine-derived nitrosamine ketone (NNK) and arecoline exposure promotes carcinogenesis and head and neck squamous cell carcinoma (HNSCC) progression, although most associated data on the two were analyzed individually. The molecular mechanisms underlying tumor progression associated with the synergistic effects of NNK and arecoline remain unclear. We treated SCC-25 and FaDu cells with NNK and arecoline (separately or in combination) for 3 months. Comparative analysis was performed to investigate the mechanism underlying the acquisition of properties related to tumor promotion, including stemness, anti-apoptosis, and resistance to HNSCC therapeutics. Long-term exposure to NNK and arecoline resulted in an increase in cancer stem cell properties, anti-apoptosis, and the resistance to cisplatin in HNSCC. We detected abundant epidermal growth factor receptor (EGFR) expression in HNSCC cells after combined treatment with NNK and arecoline. EGFR was pivotal in inducing tumor promotion and anti-apoptosis in cancer cells by inducing pAKT and NFκB. Combined treatment with NNK and arecoline synergistically facilitated tumor aggressiveness via EGFR-AKT signaling. Targeting EGFR-AKT signaling may be a feasible strategy for treat...Continue Reading

References

Mar 20, 2002·Addiction Biology·G A LordT J Peters
Mar 20, 2002·Addiction Biology·Nai-Shin Chu
Oct 23, 2003·Nature Reviews. Cancer·Stephen S Hecht
Apr 2, 2005·Nature Reviews. Cancer·Michael DeanSusan Bates
Apr 8, 2006·Proceedings of the National Academy of Sciences of the United States of America·Piyali DasguptaSrikumar Chellappan
Jul 25, 2006·The Journal of Clinical Investigation·Piyali DasguptaSrikumar Chellappan
Mar 21, 2007·Toxicological Sciences : an Official Journal of the Society of Toxicology·Helen Pui Shan WongChi-Hin Cho
May 20, 2009·Biochemical and Biophysical Research Communications·Yu-Chih ChenWen-Liang Lo
Jun 12, 2010·Molecular Cancer·Rajakishore Mishra
Aug 7, 2010·Scandinavian Journal of Public Health·Fawad JavedKhalid Almas
Dec 17, 2010·Nature Reviews. Cancer·C René LeemansRuud H Brakenhoff
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Jun 21, 2011·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Nov 18, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Heath D SkinnerJeffrey N Myers
Mar 13, 2012·Seminars in Cancer Biology·Neha TiwariGerhard Christofori
Aug 28, 2012·Bioorganic & Medicinal Chemistry Letters·Jerald J NairJohannes van Staden
May 15, 2013·Asia-Pacific Journal of Public Health·Han SongYong-Yong Xu
Jun 12, 2013·Bioorganic & Medicinal Chemistry Letters·Kinga ChojnackaNicole A Horenstein
Nov 5, 2013·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Radim HavelekZuzana Bilkova
Nov 19, 2015·Current Medicinal Chemistry·Jerald J NairJaume Bastida
Oct 23, 2016·Oncotarget·Shan HuangRandy Y C Poon
Oct 16, 2016·Best Practice & Research. Clinical Haematology·Gera D Te Raa, Arnon P Kater

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis
Assay

Software Mentioned

SPSS

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.